Jose Lutzky - Dissemin

Papers authored by Jose Lutzky

This paper is made freely available by the publisher.

2010 Kazuo Koyanagi, Steven J. O'Day, Peter Boasberg, Michael B. Atkins, He-Jing Wang, Rene Gonzalez, Karl Lewis, John A. Thompson, Clay M. Anderson, Jose Lutzky

, Thomas T. Amatruda, Evan Hersh, Jon Richards, Jeffrey S. Weber, Dave S. B. Hoon

Serial Monitoring of Circulating Tumor Cells Predicts Outcome of Induction Biochemotherapy plus Maintenance Biotherapy for Metastatic Melanoma

Download from aacrjournals.org

This paper is available in a repository.

Jedd D. Wolchok, Bart Neyns, Gerald Linette, Sylvie Negrier, Jose Lutzky

, Luc Thomas, William Waterfield, Dirk Schadendorf, Michael Smylie, Troy Guthrie, Jean-Jacques Grob, Jason Chesney, Kevin Chin, Kun Chen, Axel Hoos and 2 other authors

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study

Download from www.researchgate.net

2009 Samuel Ejadi, Steven J. O'Day, Michael B. Atkins, O'Day Sj, Peter Boasberg, He-Jing Wang, John A. Thompson, Atkins Mb, Wang Hj, Thompson Ja, Clay M. Anderson, Anderson Cm, Rene Gonzalez, Jose Lutzky

, Thomas Amatruda and 4 other authors

Phase II Multicenter Trial of Maintenance Biotherapy After Induction Concurrent Biochemotherapy for Patients With Metastatic Melanoma

Download from doi.org

Sundar Jagannath, Brian G. M. Durie, Jeffrey Lee Wolf, Elber S. Camacho, David Irwin, Jose Lutzky

, Marti McKinley, Phyllis Potts, Afshin Eli Gabayan, Amitabha Mazumder, John Crowley, Robert Vescio

Extended follow‐up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myeloma

Download from www.researchgate.net

This paper was not found in any repository, but could be made available legally by the author.

Jose Lutzky

, Robert Weber, Yvonne Nunez, Matt Gillett, Lynn Spitler

A Phase 1 Study of Granulocyte Macrophage Colony-stimulating Factor (Sargramostim) and Escalating Doses of Thalidomide in Patients With High-risk Malignant Melanoma:

Upload

2008 R. L. Johnston, J. Lutzky

, A. Chodhry, J. S. Barkin

Cytotoxic T-Lymphocyte-Associated Antigen 4 Antibody-Induced Colitis and Its Management with Infliximab

Upload

Jose Lutzky

, Juergen Bauer, Boris C. Bastian

Dose-dependent, complete response to imatinib of a metastatic mucosal melanoma with a K642E KIT mutation

Upload

Alessandro Testori, Jon Richards, Eric Whitman, G. Bruce Mann, G. Bruce Mann, Jose Lutzky

, Luis Camacho, Giorgio Parmiani, Giulio Tosti, John M. Kirkwood, Axel Hoos, Lianng Yuh, Renu Gupta, Pramod K. Srivastava

Phase III Comparison of Vitespen, an Autologous Tumor-Derived Heat Shock Protein gp96 Peptide Complex Vaccine, With Physician's Choice of Treatment for Stage IV Melanoma: The C-100-21 Study Group

Download from doi.org

2006 James R. Berenson, Ralph Boccia, David Siegel, Marek Bozdech, Alberto Bessudo, Edward Stadtmauer, J. Talisman Pomeroy, Ronald Steis, Marshall Flam, Jose Lutzky

, Syed Jilani, Joseph Volk, Siu-Fun Wong, Robert Moss, Ravi Patel and 5 other authors

Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: A prospective, multicentre, phase II, single-arm study

Download from www.researchgate.net

Karl D. Lewis, John A. Thompson, Jeffrey S. Weber, William A. Robinson, Steven O'Day, Jose Lutzky

, Sewa S. Legha, Simon Floret, Francis Ruvuna, Rene Gonzalez

A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma

Upload

2005 John B. Alexis, Antonio E. Martinez, Jose Lutzky

An immunohistochemical evaluation of c-kit (CD-117) expression in malignant melanoma, and results of imatinib mesylate (Gleevec) therapy in three patients:

Upload

Sundar Jagannath, Brian G. M. Durie, Jeffrey Wolf, Elber Camacho, David Irwin, Jose Lutzky

, Marti McKinley, Eli Gabayan, Amitabha Mazumder, David Schenkein, John Crowley

Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma

Download from www.researchgate.net

2002 Jose Lutzky

, Ana M. Gonzalez-Angulo, Jennifer A. Orzano

Antibody-based vaccines for the treatment of melanoma

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2000 R. Lilenbaum, R. Cano, M. Schwartz, L. Siegel, J. Lutzky

, M. Lewis, E. Krill, L. Barreras, E. Davila

Gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: a phase II study.

Upload

Kenneth A. Foon, Jose Lutzky

, Rathindra N. Baral, John R. Yannelli, Laura Hutchins, April Teitelbaum, Oscar L. Kashala, Ruma Das, Juanita Garrison, Ralph A. Reisfeld, Malaya Bhattacharya-Chatterjee

Clinical and Immune Responses in Advanced Melanoma Patients Immunized With an Anti-Idiotype Antibody Mimicking Disialoganglioside GD2

Upload

1995 Jonathan Cho, Young Lee, Jose Lutzky

, Leslie Redpath, Lewis Slater

Collateral sensitivity to radiation and CIS-platinum in a multidrug-resistant human leukemia cell line

Upload

1993 G. Bullock, C. Tang, E. Tourkina, Ibrado Am, J. Lutzky

, Y. Huang, Mahoney Me, K. Bhalla

Effect of combined treatment with interleukin-3 and interleukin-6 on 4-hydroperoxycyclo-phosphamide-induced programmed cell death or apoptosis in human myeloid leukemia cells.

Upload

M. K. Samoszuk, E. Ramzi, F. Wang, H. Majmundar, A. L. Anderson, L. M. Slater, P. Braunstein, J. Lutsky, Jose Lutzky

Radioimmunodetection of Hodgkin's Disease and Non-Hodgkin's Lymphomas with Monoclonal Antibody to Eosinophil Peroxidase

Download from www.researchgate.net

1992 K. Bhalla, G. Bullock, J. Lutzky

, C. Holladay, Ibrado Am, M. Jasiok, S. Singh

Effect of combined treatment with interleukin-3 and interleukin-6 on 4-hydroperoxycyclophosphamide-mediated reduction of glutathione levels and cytotoxicity in normal and leukemic bone marrow progenitor cells.

Upload

Kapil Bhalla, Charles Holladay, Jose Lutzky

, Ana Maria Ibrado, Gloria Bullock, Michelle Jasiok, Shivendra Singh

Deoxycytidine protects normal bone marrow progenitors against Ara-C and gemcitabine cytotoxicity without compromising their activity against cisplatin-resistant human ovarian cancer cells

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

Papers authored by Jose Lutzky